Actively Recruiting
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
Led by Mayo Clinic · Updated on 2026-02-25
2000
Participants Needed
1
Research Sites
1047 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is being done to create a resource of samples and information that can be used to improve our understanding of the development, progression and treatment of recurrent or metastatic breast cancer or male breast cancer.
CONDITIONS
Official Title
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female participants must have histologically or cytologically confirmed invasive breast cancer.
- Male participants must have biopsy proven breast cancer.
- Age must be >= 18 years.
- Participants must be able to understand and willing to sign an informed consent document.
You will not qualify if you...
- Dementia, altered mental status, or any psychiatric condition that would prohibit understanding or giving informed consent.
- History of serious or life-threatening allergic reaction to local anesthetics such as lidocaine or xylocaine.
- Any condition the treating oncologist or biopsy physician believes would make participation unreasonably hazardous for the patient.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here